228 results about "Mucin" patented technology

The invention relates to the technical field of grinding and crushing, and discloses hippocampus active mucoprotein grinding equipment and an extraction technology.The hippocampus active mucoprotein grinding equipment comprises a shell, a motor is fixedly installed at the bottom of the shell, a driving shaft is fixedly installed at the output end of the top of the motor, and a primary grinding assembly is detachably installed at the top end of the driving shaft; a secondary grinding assembly is fixedly installed on the circumferential face of the upper half portion of the driving shaft, an annular sieve tray is fixedly installed on the inner wall of the middle of the shell, and a vibration assembly is arranged on the surface of the driving shaft. The shoveling plate is driven by the rotating cover to move at the top of the annular screening disc, hippocampus on the bottom layer of the annular grinding groove is thrown upwards, the hippocampus enters the space between the hollow rotating roller and the outer convex ring and the space between the hollow rotating roller and the inner convex ring, and the hollow rotating roller rotates while moving along the annular grinding groove. The outer wall of the hollow rotating roller is matched with the outer convex ring and the inner convex ring to extrude and crush the hippocampus, so that secondary grinding of the hippocampus is realized; therefore, the purposes of grinding the hippocampal tissue twice and improving the grinding efficiency are achieved.

The invention belongs to the technical field of gel dressings, and particularly relates to a bio-based gel dressing for wound treatment and a preparation method thereof.The bio-based gel dressing is prepared from, by weight, 10-17 parts of mussel mucin, 13-20 parts of silk fibroin, 1-5 parts of plant vesicles, 2-4 parts of traditional Chinese medicine polysaccharide, 0.05 part of antibacterial peptide, 1.5 parts of glycerinum and 0.3 part of cross-linking agent; nano plant vesicles which are extracted from a traditional Chinese medicine prescription and have the effect of promoting wound healing are used as a carrier for encapsulating antibacterial peptide, and then the antibacterial peptide is encapsulated in a three-dimensional gel network formed by natural protein, so that controlled release and slow release of antibacterial and anti-inflammatory components are realized, and efficient wound healing is promoted.

The invention is suitable for the technical field of gynecological gels, and provides a gynecological gel with a repairing effect. Comprising the following components in percentage by weight: 0.1%-0.5% of recombinant III type human collagen, 0.05%-0.2% of mussel mucin, 1%-3% of chitosan, 0.2%-1% of sodium hyaluronate, 2%-5% of lactobacillus fermentation product filtrate, 0.05%-0.2% of tea tree essential oil, 0.2%-0.5% of carbomer, 0.1%-0.4% of triethanolamine, 0.1%-0.2% of sodium methylparaben and the balance of purified water. The gynecological gel with the repairing effect has the excellent repairing effect, integrates multiple effects of effectively resisting bacteria and diminishing inflammation, promoting repairing of damaged vaginal mucosa, adjusting vaginal micro-ecological balance and the like, not only can efficiently inhibit growth of various pathogens, but also can remarkably promote proliferation and repairing of vaginal mucosa cells, and has the advantages that the repairing effect is good, and the repairing effect is good. The vaginal micro-ecological balance can be accurately adjusted, no stimulation is caused to vaginal mucosa, safety and reliability are achieved, and long-term use can be achieved.

The invention provides a nano transdermal sustained-release biological scaffold as well as a preparation method and application thereof, and belongs to the technical field of biomedical materials. The nano transdermal sustained-release biological scaffold provided by the invention comprises the following components: a load and a nano carrier, the load comprises mussel mucin, trehalose and Ectoine; the mass ratio of the mussel mucin to the trehalose to the Ectoine is (4 to 6) to (0.5 to 1.5) to (0.5 to 2.0). Through the innovative design of a quaternary composite system of mussel mucin, trehalose, Ectoine and a nano-carrier, the three technical problems of short slow release period, insufficient targeting property and difficulty in large-scale production in a wound repair material in the prior art are successfully solved.

The invention relates to the technical field of biomedical materials, in particular to an oral repair film and a preparation method and application thereof. The oral repair membrane comprises an electrostatic spinning membrane with the porosity of 30%-40%, and polymer microspheres, recombinant humanized collagen and mussel mucoprotein which are attached to the electrostatic spinning membrane, wherein the particle size of the polymer microspheres is 25 [mu] m-50 [mu] m. According to the oral cavity repairing film provided by the invention, by combining a polymer electrostatic spinning technology, a shearing and emulsifying microsphere preparation technology, a microsphere slow release technology and a three-dimensional porous bracket freeze-drying technology, the problems that a repairing film in the marketed or published technology is small in contact area and needs to be sewn are solved; the tissue regeneration can be efficiently stimulated, the treatment time is shortened, the treatment effect is improved, suturing is not needed, and clinical operation is facilitated.

Provided herein are compositions, methods, and uses involving anti-Mucin-16 (MUC16) agents that immunospecifically bind an epitope of Mucin-16 (MUC16). Also provided herein are uses and methods for managing, treating, or preventing disorders, such as cancer and diseases associated with positive MUC16 expression.

The invention provides hydrogel with a wound healing function and a preparation method thereof.The hydrogel is prepared from, by mass, 50-70 parts of basic gel matrix, 20-30 parts of natural medicine extract and 8-10 parts of bioactive ingredients; the natural medicine extract comprises superfine pearl powder, a semen cassiae extract, an aloe extract, a cortex phellodendri extract, a honeysuckle flower extract, a dandelion extract, a centipede extract, a fructus forsythiae extract and a green tea extract; the bioactive components comprise epidermal growth factors, heparin sodium, mussel mucin and nano-silver ions; on the basis of a commercially available compound cortex phellodendri liniment, further research and development are carried out, the superfine pearl powder, the semen cassiae extract, the aloe extract, the green tea extract and other natural medicine components are added, the optimal proportion is selected, and the basic gel matrix, the bioactive components and the like are combined, so that the wound healing rate, the antibacterial rate and the water holding rate of the hydrogel are remarkably improved finally.

The application discloses a preparation method of high-purity recombinant mussel adhesive protein and belongs to the technical field of recombinant protein preparation. The amino acid sequence of Mfp-3 of Mytilus coruscus and the partial peptide segment of the amino acid sequence of preCol-D of Mytilus edulis are fused and expressed according to the idea of improving target protein expression by using fusion protein, and the improvement of the induction, tyrosinase modification and separation and purification process is combined to obtain the recombinant mussel adhesive protein with high purity, low endotoxin content and good adhesion performance. The successful preparation of the recombinant mussel adhesive protein provides a new idea for the industrial production of the recombinant mussel adhesive protein, provides raw material support for the multi-field application of the recombinant mussel adhesive protein, realizes the preparation of the customized sequence recombinant mussel adhesive protein according to application requirements, and promotes the application of the mussel adhesive protein in different fields.

The invention relates to the field of molecular biology, and discloses a nucleic acid releasing agent for isothermal amplification and a use method of the nucleic acid releasing agent. Comprising the following steps: step 1, preparing a polyoxypropylene polyoxyethylene copolymer diluent, a defoaming agent SE-15 diluent, an ethyl phenyl polyethylene glycol NP-40 diluent, a sodium polyethylene sulfonate diluent and a Proclin300 diluent in sequence through RNA enzyme-free water; and 2, sequentially preparing an ethylenediamine tetraacetic acid disodium salt mother solution, a sodium dodecyl sulfate mother solution and a glycine mother solution through RNA enzyme-free water. Sodium polyethylene sulfonate can be specifically combined with protein amplification inhibitors in a sample to remove mucoprotein, hemoglobin, polysaccharide and other inhibitors in the swab sample, and disodium ethylene diamine tetraacetate can chelate metal ions to reduce the influence of nuclease on target nucleic acid.

The invention relates to a recombinant mussel-like mucoprotein as well as a coding gene and application thereof, and belongs to the technical field of gene engineering and protein engineering. According to the invention, partial functional sequences of different types of mussel mucin are screened, assembled and spliced to obtain a section of brand new mussel mucin-like sequence, and the sequence is optimized by escherichia coli codon preference to construct a high-expression recombinant strain. According to the recombinant strain, the soluble expression quantity of the target protein is remarkably improved by optimizing culture conditions. The recombinant protein does not carry any exogenous tag, and the provided purification method is low in cost, high in yield and suitable for large-scale production. The prepared recombinant mussel-like protein has good adhesiveness and oxidation resistance, and the modified recombinant mussel-like protein is further provided, and the biological performance of the modified recombinant mussel-like protein is better than that of unmodified recombinant mussel-like protein.

The invention relates to the technical field of protein design, and particularly discloses an Mfp-SOD recombinant protein as well as a preparation method and application thereof. According to the recombinant protein, mussel mucin Mfp-3 is used as a skeleton to assist anchoring of human-derived protein SOD, and a novel recombinant protein is obtained. According to the recombinant protein, two proteins are fused, so that the recombinant protein has excellent skin surface affinity and the functions of oxidation resistance, aging resistance, whitening, spot fading, inflammation resistance, sunscreen and the like, and the effects of oxidation resistance and aging resistance can be exerted for a long time.

Disclosed herein are double stranded ribonucleic acids (dsRNAs) and synthetic antisense oligonucleotides (ASOs) for use in inhibiting the expression of MUC5B and in the treatment of a subject having a disease or disorder characterized by overexpression of MUC5B, including in subjects having lung disease or in a subject at risk of developing lung disease, for example, in a subject having or at risk of developing idiopathic pulmonary fibrosis.

The application relates to the technical field of protein design, and particularly discloses a kind of Mfp-SOD recombinant proteins and a preparation method and application thereof.The recombinant protein takes the mussel mucin Mfp-3 as a skeleton, assists anchoring human-derived protein SOD, and obtains a new type of recombinant protein.The recombinant protein is fused by two kinds of proteins, has excellent skin surface affinity and functions of antioxidation, anti-aging, whitening, spot-fading, anti-inflammation and sun protection, and can achieve long-acting antioxidation and anti-aging effects.

The application provides a mussel mucin synthesis method and relates to the technical field of genetic engineering.The application improves the yield of mussel mucin by carrying out deletion mutation on the N-terminal sequence of the secondary structure of the mussel mucin amino acid sequence such as SEQ ID NO.1.The yield of mussel mucin in the prior art is about 2.57g / L, while the yield of mussel mucin in the application is about 5g / L, which is greatly improved compared with the yield of mussel mucin in the prior art.On this basis, the mussel mucin is modified by dopa through co-expression of tyrosinase, and the expression amount of the tyrosinase is controlled through different intensities of RBS, so as to regulate the modification degree of dopa, improve the yield of mussel mucin, and realize controllable modification of dopa in the mussel mucin, finally obtaining mussel mucin with high yield and different modification degrees of dopa.

This application discloses a mussel mucin hydrogel dressing with self-repairing function and its preparation method. The dressing comprises a gel system comprising a composite hydrogel matrix and a functionalized nano-modified component. The composite hydrogel matrix comprises a network structure formed by photoenzyme-assisted crosslinking of mussel mucin, methacryloylated gelatin, and phenylboronic acid-modified gelatin. The weight ratio of the mussel mucin, methacryloylated gelatin, and phenylboronic acid-modified gelatin is (2-5):(15-20):5. The functionalized nano-modified component comprises mesoporous silica nanoparticles loaded with small molecule polypeptides and graphene oxide, wherein the graphene oxide accounts for 0.1-0.5 parts by weight in the gel system; the mesoporous silica nanoparticles account for 1-3 parts by weight in the gel system, and the polypeptide loading rate is 30-50%. This application addresses the shortcomings of traditional wound repair materials in terms of adhesion stability, antibacterial properties, and anti-inflammatory properties.

The invention belongs to the technical field of biological detection, and discloses a sequence combination for rapidly detecting influenza A based on CRISPR / CAS12a-MIRA and application, the sequence combination comprises an MIRA primer pair (SEQ ID NO: 1-2) of a targeted influenza A virus M gene highly conserved region (M1 fragment), and CRISPR / Cas12a detection probes (crRNA SEQ ID NO: 3 and phosphorothioate modified FAM-biotin probe SEQ ID NO: 4). By optimizing a buffer system (containing PEG 8000 and betaine), MIRA amplification and CRISPR detection are continuously completed in a closed tube at 37-42 DEG C, and a result is output within 30 minutes. The detection sensitivity of the kit reaches 50 copies / [mu] L, the specificity is 100%, and subtypes such as H1N1, H3N2, H5N1 and H7N9 can be covered. Compared with the prior art, according to the scheme, the detection time is shortened by 67%, the probe cost is reduced by 80%, and high anti-interference performance (tolerance to 10% mucoprotein and 5% whole blood) is achieved. The kit is suitable for on-site instant detection of saliva, nasopharynx swabs and environmental samples, and an efficient and portable solution is provided for basic medical institutions and prevention and control of sudden epidemic situations.

The application discloses a plant lactobacillus strain and application thereof, and belongs to the technical field of microorganisms. The preservation number of the strain is CGMCC No. 33864. The strain has good tolerance to gastrointestinal juice and bile salts and has no hemolytic activity. Concentrated cell-free supernatant prepared from the strain can inhibit salmonella, including inhibiting the growth of salmonella, killing bacteria, inhibiting or removing biofilm. Animal experiments show that the strain and the concentrated cell-free supernatant thereof can prevent salmonella infection, alleviate weight loss caused by infection, maintain intestinal barrier integrity, reduce the level of pro-inflammatory factors, alleviate tissue damage, improve the expression of colon tight junction proteins and mucin, promote the generation of short-chain fatty acids, and restore the intestinal flora structure. The application further provides a microbial preparation containing the strain and / or the concentrated cell-free supernatant thereof. The strain and the microbial preparation can be used for preparing products for resisting salmonella, preventing salmonella infection or improving intestinal health.

The invention relates to the technical field of biological medicine, in particular to mussel mucin and hyaluronic acid cross-linked self-repairing eye health care cream and a 4D forming method thereof. The composition comprises stearic acid, cetostearyl alcohol and the like, a lactic acid bacteria fermentation extract, a jasmine flower extract, a wolfberry extract, a pseudo-ginseng extract, a cassia seed extract, a polygonum cuspidatum extract, a chrysanthemum extract, a leontopodium leontopodum extract, ethylparaben, methylparaben and the like, decapeptide-4, mussel mucin, proteoglycan protein and modified graphene. Modified graphene in the self-repairing eye health care cream can effectively promote crosslinking of mussel mucin and hyaluronic acid and improve the repairing effect, the micro-current effect of graphene can also promote skin tissue to absorb traditional Chinese medicine components and deeply repair eyes, the effect can be more obvious according to personal eye conditions and requirements, and the self-repairing eye health care cream has a good application prospect. The composition has the effects of relieving asthenopia, dryness and soreness, effectively delaying excessive growth of an ocular axis, relieving temporary myopia drift, relieving asthenopia and protecting near vision.

The present application relates to the technical field of wound repair, and provides a traditional Chinese medicine composition for promoting wound healing and a preparation method thereof.The traditional Chinese medicine composition comprises a first traditional Chinese medicine composition and a second traditional Chinese medicine composition which are applied to the acute phase and the repair proliferation phase.The former comprises naked flower purple perilla extract, nectarine leaf extract, purple perilla extract, dragon's blood micro powder, spironast extract, centella asiatica volatile oil, rhubarb extract, borneol, mussel mucin, medicinal glycerol and purified water.The latter comprises red algae extract, nectarine leaf extract, radix astragali extract, panax notoginseng total saponins, aloe extract, dendrobium officinale extract, sea buckthorn extract, pinctada martensii purified peptide, snail glycosaminoglycan, medicinal glycerol and purified water.The composition can play the roles of antibiosis, anti-inflammation, hemostasis, analgesia and astringency in the acute phase, and can promote angiogenesis, collagen synthesis and epithelial regeneration in the repair proliferation phase, so that the wound is rapidly repaired and healed.

The application provides a dengue virus protection and mosquito vector control antigen composition and application thereof. The antigen composition comprises a combination of dengue virus type 1-4 envelope protein domain III polypeptide and Aedes aegypti midgut mucin AaMuc1 antigen polypeptide; the amino acid sequences of the dengue virus type 1-4 envelope protein domain III polypeptide are respectively shown as SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3 and SEQ ID NO. 4; and the amino acid sequence of the Aedes aegypti midgut mucin AaMuc1 antigen polypeptide is shown as SEQ ID NO. 5. The prepared vaccine can induce the body to produce neutralizing antibodies against dengue virus type 1-4, achieve the protection of human body from dengue virus infection, induce the production of active antibodies targeting Aedes aegypti midgut mucin 1, inhibit and kill the dengue virus transmission vector Aedes aegypti, and achieve the dual prevention and control of dengue fever from two dimensions of infection prevention and transmission interruption.

The present disclosure provides a composition useful for in vitro assessment of the effect of an analyte, such as a food or drug candidate compound, on mammal, particularly human, intestinal flora. Specifically, the present disclosure provides a polymeric glycoprotein-containing composition for promoting and / or maintaining original equilibration when culturing intestinal flora in a culture medium. The composition is used so that a mucin, for example, is included in a culture medium. A GAM culture medium or a modification thereof can be used as the culture medium.

The invention belongs to the technical field of oral implant materials, and relates to a magnesium metal-guided bone regeneration membrane, a preparation method thereof and a product for preparing the magnesium metal-guided bone regeneration membrane. The magnesium metal-guided bone regeneration membrane comprises a bone repair combination product of the magnesium metal-guided bone regeneration membrane. The preparation method comprises the following steps: respectively providing an electrochemical deposition solution and a polysaccharide-containing solution; the electrochemical deposition liquid comprises a calcium ion donor, a phosphate ion donor and mussel mucin; the method comprises the following steps: placing a magnesium metal matrix in an electrochemical deposition solution, and carrying out first-stage electrochemical deposition under a first electrochemical deposition condition to prepare an intermediate 1; placing the intermediate 1 in an electrochemical deposition solution, performing second-stage electrochemical deposition under a second electrochemical deposition condition, cleaning, and drying to prepare an intermediate 2; placing the intermediate 2 in a solution containing polysaccharide, dip-coating the polysaccharide, and drying; the first electrochemical deposition condition and the second electrochemical deposition condition are respectively as follows: the voltage is 1-5V and 10-60V; the membrane has the biological functions of low corrosion rate, high bonding strength, inflammation resistance, bacteria resistance, osteogenesis promotion and the like.

The invention relates to the field of cell culture and discloses a culture medium for thick-shelled mussel mantle cells and an application thereof. The culture medium comprises a basal culture medium and additives, wherein the additives comprise thick-shelled mussel serum, proanthocyanidins, bovine insulin, growth factors, antibiotics, defensins, mussel mucin and a buffer. The culture medium can be used for in vitro culture of thick-shelled mussel mantle cells and can better maintain the survival and growth of in vitro cultured thick-shelled mussel mantle cells. Defensins in a specific proportion are added to the culture medium, and the best growth and reproduction state can be achieved when the thick-shelled mussel mantle cells are cultured using the culture medium in the specific proportion. The application also provides an application method of the culture medium, which is simple to operate and can produce cultured thick-shelled mussel mantle cells with high cell density, good morphology and high wall adhesion.

The invention relates to a chemoenzymatic synthesis method of a high-glucose-type homogeneity mucoprotein core structural domain. The method comprises the following steps: firstly, catalytically synthesizing a key alpha-linked glycosylated amino acid block Fmoc-GalNacalpha-Ser / Thr-OH at a low temperature (-20 DEG C to 0 DEG C); then assembling the building blocks on a repeated polypeptide skeleton rich in proline, serine and threonine at accurate intervals (3-5 amino acid residues) through a solid-phase peptide synthesis technology to form a'sugar chain growth scaffold '; then, a series of high-specificity glycosyl transferases are used for carrying out sequential and directional sugar chain enzymatic extension on the scaffold, and a uniform core structure (such as a core type 3) is constructed; and finally, performing high-efficiency purification by a three-step series method of size exclusion chromatography, ion exchange chromatography and lectin affinity chromatography. The technical bottleneck of inhomogeneity (lt, 70%) of glycoforms in a traditional method is overcome, the mucoprotein core fragment with glycoform homogeneity larger than or equal to 95% and bioactivity highly similar to that of natural mucoprotein can be prepared on a large scale, and the method has wide application prospects in the biomedical fields of mucous membrane protective agents, drug delivery carriers and the like.

The present invention relates to Akkermansia muciniphila and its applications, belonging to the technical field of microbiology. The Akkermansia muciniphila described in the present invention is Akkermansia muciniphila SYSU-85, which was deposited on August 8, 2024 at the General Microbiological Center of the China General Microbiological Culture Collection Center, and its deposit number is: CGMCC NO. 46070. The Akkermansia muciniphila SYSU-85 of the present invention has a weak dependence on mucin, grows well in BHI medium supplemented with cysteine, and is resistant to oxaliplatin. The Akkermansia muciniphila SYSU-85 of the present invention alleviates the adverse reactions caused by oxaliplatin, and in combination with oxaliplatin or PD-1 inhibitor, significantly slows down the tumor growth curve and significantly reduces the tumor volume, improving the tumor treatment effect.

The invention discloses a bionic cross-linked film-forming repair dressing containing mussel mucoprotein and a preparation method of the bionic cross-linked film-forming repair dressing, and relates to the technical field of medical instruments. The bionic crosslinking film-forming repair dressing containing the mussel mucoprotein is prepared from the following components in parts by weight: 30 to 40 parts of bionic crosslinking agent, 25 to 35 parts of humectant, 10 to 20 parts of natural high polymer material, 1 to 10 parts of mussel mucoprotein, 1000 parts of purified water and 5 to 15 parts of pH regulator. PEG-DOPA is formed through cross-linking, the DOPA content and stability are remarkably improved, the adhesion-repair-anti-inflammatory effect of mussels mainly depends on the dopa content, the effect of the dressing is remarkably enhanced through improvement of the DOPA content and stability, the dressing is more convenient to use through the flexibility change of a film, the dressing is more suitable for dynamic and wet wounds, and the application range of the dressing is widened. The medicine has a remarkable effect on chronic ulcer and burn.

The invention discloses a nasal cavity biological protection preparation, a preparation method and application thereof and a nasal cavity intelligent protection system. The formulation comprises a mucin inspired polymer having a specific "brush-like bottleneck" molecular configuration, and an interpenetrating network formed from oppositely charged polysaccharides, which construct a three-dimensional hydrated gel by dynamic non-covalent cross-linking. The gel has the characteristics of shear thinning, strong mucous membrane adhesion and efficient particle interception. Temperature-sensitive, pH-sensitive or oxidation-reduction-sensitive intelligent microspheres can also be integrated in the preparation, so that responsiveness protection to the external environment is realized. The invention further provides an intelligent protection scheme comprising the preparation, a quantitative spraying device and a simple monitoring system. The preparation is safe and free of medicine, is suitable for preventing nasal cavity discomfort caused by air pollution, allergens, viruses and environment dryness, and is especially suitable for daily health protection under high-risk environment or extreme weather conditions.

The present invention discloses a composition for improving rhinitis symptoms and nasal cleaning, as well as its preparation method and application. The composition comprises, by weight, 0.1 to 7 parts of yeast β-glucan and 0.1 to 6 parts of mussel mucin. The present invention prepares a composition for improving rhinitis symptoms and nasal cleaning by rationally combining ultra-low molecular weight yeast β-glucan, low molecular weight yeast β-glucan, medium molecular weight yeast β-glucan, high molecular weight yeast β-glucan, and mussel mucin. The composition can be effectively used for nasal cleaning of patients with nasal diseases such as acute rhinitis, chronic rhinitis, allergic rhinitis, nasal polyps, sinusitis, etc., and can also be used for nasal cleaning after nasal tumor surgery or chemotherapy.

The present application relates to a kind of mussel-based composite coacervate based on mussel adhesive protein and its preparation method and purposes, the mussel-based composite coacervate includes mussel adhesive protein and anionic polyelectrolyte material;The mass ratio of mussel adhesive protein and anionic polyelectrolyte material is (0.05~4):1;The oxidation rate of dopa residue in the mussel adhesive protein in the composite coacervate is 0.1%~70.0%.The present application realizes the accurate control of the preparation of the composite coacervate formed by regulating the concentration, mass ratio and system pH of mussel adhesive protein and anionic polyelectrolyte material, and then improves its performance and effect as tissue adhesive, wound repair dressing, acute hemostatic material, local drug delivery carrier and drug release system field or bone tissue repair, cartilage repair and tissue filling and support field.

The invention belongs to the technical field of intestinal health care, and relates to a composition containing a milk fat globular membrane and application of the composition. The composition comprises the following components in parts by weight: 0.1 to 0.4 part of a milk fat ball membrane, 0.4 to 2.4 parts of fructo-oligosaccharide, 0.1 to 1 part of xylooligosaccharide, 0.1 to 0.5 part of stachyose and 0.1 to 0.5 part of metabiotics. The composition can increase beneficial bacteria, inhibit growth of harmful bacteria and increase intestinal peristalsis; the intestinal permeability is regulated; meanwhile, the level of tight junction protein and mucoprotein in the intestinal tract is adjusted, and the intestinal tract barrier is enhanced; the intestinal inflammation level can also be regulated. The composition improves intestinal health through multiple targets, and has a remarkable effect on improving intestinal problems such as constipation and inflammatory bowel diseases; meanwhile, depression and anxiety mood caused by intestinal problems can be relieved, the life quality is improved, and the traditional Chinese medicine composition is more beneficial to overall health of organisms and can be taken for a long time.